Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes

NCT00562133 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Insulin Glulisine
DRUG: Insulin

Sponsor

IKFE Institute for Clinical Research and Development